$AHR
American Healthcare REIT, Inc. Stock $ahr

$ahr Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000163297024000085 Filed on August 09, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$476.8M	$458.0M
YoY Change	14.57%	11.54%
Cost Of Revenue	$417.1M	$402.6M
YoY Change	11.35%	8.06%
Gross Profit	$59.71M	$55.45M
YoY Change	43.51%	45.64%
Gross Profit Margin	12.52%	12.11%
Selling, General & Admin	$25.07M	$25.07M
YoY Change	-3.26%	-5.14%
% of Gross Profit	41.99%	45.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$37.61M	$36.87M
YoY Change	1.84%	-0.74%
% of Gross Profit	62.99%	66.49%
Operating Expenses	$69.32M	$70.33M
YoY Change	-7.81%	-1.12%
Operating Profit	$93.54M	$88.69M
YoY Change	24.61%	10.36%
Interest Expense	$30.40M	$30.60M
YoY Change	-27.64%	-25.36%
% of Operating Profit	32.5%	34.5%
Other Income/Expense, Net	-$36.66M	-$28.06M
YoY Change	87.18%	-18.73%
Pretax Income	-$2.830M	$3.612M
YoY Change	-54.07%	-131.36%
Income Tax	$263.0K	$686.0K
% Of Pretax Income		18.99%
Net Earnings	-$4.126M	$1.979M
YoY Change	-31.11%	-116.24%
Net Earnings / Revenue	-0.87%	0.43%
Basic Earnings Per Share	-$0.03	$0.01
Diluted Earnings Per Share	-$0.03	$0.01
COMMON SHARES
Basic Shares Outstanding	131.6M shares	130.5M shares
Diluted Shares Outstanding	133.7M shares	130.7M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$67.85M	$52.09M
YoY Change	92.88%	7.6%
Cash & Equivalents	$67.85M	$52.09M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$20.23M	$20.04M
Prepaid Expenses
Receivables	$203.7M	$201.0M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$271.5M	$253.1M
YoY Change	32.67%	30.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.709B	$3.687B
YoY Change	1.21%	-1.61%
Goodwill	$234.9M	$234.9M
YoY Change	0.0%	0.0%
Intangibles	$177.8M	$179.5M
YoY Change	-9.69%	-14.8%
Long-Term Investments	$16.26M	$18.38M
YoY Change	-21.86%	-13.75%
Other Assets	$136.6M	$137.1M
YoY Change	4.39%	7.11%
Total Long-Term Assets	$4.405B	$4.391B
YoY Change	0.48%	-1.81%
TOTAL ASSETS
Total Short-Term Assets	$271.5M	$253.1M
Total Long-Term Assets	$4.405B	$4.391B
Total Assets	$4.677B	$4.645B
YoY Change	1.92%	-0.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$269.8M	$253.7M
YoY Change	15.33%	13.46%
Accrued Expenses	$174.2M	$178.6M
YoY Change	-24.63%	-32.02%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$444.0M	$432.2M
YoY Change	-4.53%	-11.11%
LONG-TERM LIABILITIES
Long-Term Debt	$1.918B	$2.053B
YoY Change	-24.38%	-20.0%
Other Long-Term Liabilities	$57.72M	$55.34M
YoY Change	7.52%	-3.86%
Total Long-Term Liabilities	$1.976B	$2.108B
YoY Change	-23.72%	-19.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$444.0M	$432.2M
Total Long-Term Liabilities	$1.976B	$2.108B
Total Liabilities	$2.420B	$2.541B
YoY Change	-20.8%	-18.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.387B	-$1.344B
YoY Change	12.55%	11.14%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.207B	$1.933B
YoY Change
Total Liabilities & Shareholders Equity	$4.677B	$4.645B
YoY Change	1.92%	-0.47%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$4.126M	$1.979M
YoY Change	-31.11%	-116.24%
Depreciation, Depletion And Amortization	$37.61M	$36.87M
YoY Change	1.84%	-0.74%
Cash From Operating Activities	$63.13M	$59.40M
YoY Change	116.76%	36.11%
INVESTING ACTIVITIES
Capital Expenditures	$29.56M	$64.57M
YoY Change	-46.61%	0.25%
Acquisitions
YoY Change
Other Investing Activities	-$847.0K	$4.254M
YoY Change	-101.28%	-94.26%
Cash From Investing Activities	-$30.41M	-$60.31M
YoY Change	-376.08%	-722.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-13.70M	-26.03M
YoY Change	-73.46%	-63.64%
NET CHANGE
Cash From Operating Activities	63.13M	59.40M
Cash From Investing Activities	-30.41M	-60.31M
Cash From Financing Activities	-13.70M	-26.03M
Net Change In Cash	19.03M	-26.94M
YoY Change	-265.97%	47.63%
FREE CASH FLOW
Cash From Operating Activities	$63.13M	$59.40M
Capital Expenditures	$29.56M	$64.57M
Free Cash Flow	$33.57M	-$5.163M
YoY Change	-227.95%	-75.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90782000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111906000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43445000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	47337000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	46854000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90782000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48407000	usd
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q4	gahr	Heldto Maturity Debt Securities Unamortizedclosingcosts HeldtoMaturityDebtSecuritiesUnamortizedclosingcosts	489000	usd
CY2023Q2	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1046000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	2279000	usd
CY2023Q2	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	68000	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	156000	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	133000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14141000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	20611000	usd
CY2023Q2	gahr	Amortizationof Deferred Lease Inducements AmortizationofDeferredLeaseInducements	88000	usd
	gahr	Amortizationof Deferred Lease Inducements AmortizationofDeferredLeaseInducements	176000	usd
	gahr	Amortizationof Deferred Lease Inducements AmortizationofDeferredLeaseInducements	176000	usd
CY2023Q4	gahr	Number Of Variable Rate Mortgage Loans Payable NumberOfVariableRateMortgageLoansPayable	13	mortgageloan
CY2024Q2	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	9143000	usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3278806000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1344285000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2456000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1933371000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	170522000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2103893000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4644615000	usd
CY2024Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	975000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2103893000	usd
CY2024Q2	gahr	Financing Obligations FinancingObligations	40444000	usd
CY2023Q4	gahr	Financing Obligations FinancingObligations	41756000	usd
CY2024Q2	gahr	Security Deposits Prepaid Rentand Other Liabilities SecurityDepositsPrepaidRentandOtherLiabilities	49811000	usd
CY2023Q4	gahr	Security Deposits Prepaid Rentand Other Liabilities SecurityDepositsPrepaidRentandOtherLiabilities	76134000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	gahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	0	usd
CY2023Q2	gahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	6381000	usd
	gahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	0	usd
	gahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	6381000	usd
CY2024Q2	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	504581000	usd
CY2023Q2	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	467571000	usd
	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	1004114000	usd
	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	919797000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1035000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-113000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2240000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-419000	usd
CY2024Q2	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	usd
CY2023Q2	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	726000	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	82000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1068000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-344000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2076000	usd
CY2024Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	3106000	usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	2589000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	4969000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	4197000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-28057000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-34525000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-55583000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-70827000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3612000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11519000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	886000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38991000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	686000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	348000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	964000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	491000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	2926000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-11867000	usd
	us-gaap	Profit Loss ProfitLoss	-78000	usd
	us-gaap	Profit Loss ProfitLoss	-39482000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	947000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	316000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1835000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1427000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	1979000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-12183000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1913000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-38055000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130532144	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66033345	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	117413643	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66029779	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	130689889	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66033345	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	117413643	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66029779	shares
CY2024Q2	us-gaap	Profit Loss ProfitLoss	2926000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-11867000	usd
	us-gaap	Profit Loss ProfitLoss	-78000	usd
	us-gaap	Profit Loss ProfitLoss	-39482000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	12000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	124000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-31000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	246000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	12000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	124000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-31000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	246000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2938000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-11743000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-109000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-39236000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	947000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	316000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1835000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1427000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1991000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12059000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1944000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37809000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2131162000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-71000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	2765000	usd
CY2024Q2	gahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	-1137000	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2024Q2	us-gaap	Dividends Common Stock DividendsCommonStock	33074000	usd
CY2024Q2	gahr	Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend	2937000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	12000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1526989000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-72000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	1564000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	87000	usd
CY2023Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	3092000	usd
CY2023Q2	gahr	Reclassification Of Noncontrolling Interest Net ReclassificationOfNoncontrollingInterestNet	-20000	usd
CY2023Q2	gahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	621000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2023Q2	us-gaap	Dividends Common Stock DividendsCommonStock	16654000	usd
CY2023Q2	gahr	Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend	-11749000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	124000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1496402000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1425335000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	772800000	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	53542000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-71000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	4679000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	14000	usd
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-441000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1967000	usd
	gahr	Reclassification Of Noncontrolling Interest Net ReclassificationOfNoncontrollingInterestNet	15282000	usd
	gahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	-8038000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
	us-gaap	Dividends Common Stock DividendsCommonStock	66150000	usd
	gahr	Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend	-46000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-31000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2103893000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1567765000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-72000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	2615000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	41000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	165000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	6194000	usd
	gahr	Reclassification Of Noncontrolling Interest Net ReclassificationOfNoncontrollingInterestNet	-41000	usd
	gahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	-4422000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
	us-gaap	Dividends Common Stock DividendsCommonStock	33219000	usd
	gahr	Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend	-38996000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	246000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1496402000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-11000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-118000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-32000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-486000	usd
	us-gaap	Profit Loss ProfitLoss	-78000	usd
	us-gaap	Profit Loss ProfitLoss	-39482000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	88031000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	89371000	usd
	gahr	Other Amortization OtherAmortization	22645000	usd
	gahr	Other Amortization OtherAmortization	32647000	usd
	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-1880000	usd
	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-2083000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5203000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2656000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2261000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-2204000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2240000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-419000	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	726000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-332000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	2125000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1280000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Increase Decrease In Other Financial Instruments Used In Operating Activities IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities	6805000	usd
	us-gaap	Increase Decrease In Other Financial Instruments Used In Operating Activities IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities	4798000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	20839000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	9827000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	13757000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4449000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1652000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4662000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	17092000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	18866000	usd
	gahr	Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities	1919000	usd
	gahr	Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities	-3363000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	53448000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	43642000	usd
	gahr	Payments To Develop Real Estate Assets And Payments For Capital Expenditures PaymentsToDevelopRealEstateAssetsAndPaymentsForCapitalExpenditures	38375000	usd
	gahr	Payments To Develop Real Estate Assets And Payments For Capital Expenditures PaymentsToDevelopRealEstateAssetsAndPaymentsForCapitalExpenditures	52074000	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	46428000	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	12333000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	14520000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	87446000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	335000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	12000000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	14403000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	19283000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	usd
	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	131000	usd
	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	1017000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-65534000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9687000	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	27204000	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	61077000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	194560000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	55127000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	434600000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	199300000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	874823000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	199400000	usd
	gahr	Payments On Financing And Other Obligations PaymentsOnFinancingAndOtherObligations	1575000	usd
	gahr	Payments On Financing And Other Obligations PaymentsOnFinancingAndOtherObligations	7779000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7115000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1903000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	772800000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	49469000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	781000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	49594000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	43086000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	165000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	71000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	72000	usd
	gahr	Payments To Acquire Noncontrolling Interest PaymentsToAcquireNoncontrollingInterest	441000	usd
	gahr	Payments To Acquire Noncontrolling Interest PaymentsToAcquireNoncontrollingInterest	0	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1971000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	7624000	usd
	gahr	Repurchaseofstockwarrantsandredeemablenoncontrollinginterests Repurchaseofstockwarrantsandredeemablenoncontrollinginterests	36083000	usd
	gahr	Repurchaseofstockwarrantsandredeemablenoncontrollinginterests Repurchaseofstockwarrantsandredeemablenoncontrollinginterests	15954000	usd
	gahr	Increase Decrease In Security Deposits Financing Activities IncreaseDecreaseInSecurityDepositsFinancingActivities	47000	usd
	gahr	Increase Decrease In Security Deposits Financing Activities IncreaseDecreaseInSecurityDepositsFinancingActivities	-61000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18935000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-71575000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6849000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-18246000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-29000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97602000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93750000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65052000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111906000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52087000	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	45515000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	45343000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97602000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93750000	usd
	us-gaap	Interest Paid Net InterestPaidNet	62875000	usd
	us-gaap	Interest Paid Net InterestPaidNet	76013000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	734000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	797000	usd
	gahr	Developments And Capital Expenditures Incurred But Not Yet Paid DevelopmentsAndCapitalExpendituresIncurredButNotYetPaid	22098000	usd
	gahr	Developments And Capital Expenditures Incurred But Not Yet Paid DevelopmentsAndCapitalExpendituresIncurredButNotYetPaid	25664000	usd
	gahr	Finance Leases Equipment And Other Obligations Incurred FinanceLeasesEquipmentAndOtherObligationsIncurred	353000	usd
	gahr	Finance Leases Equipment And Other Obligations Incurred FinanceLeasesEquipmentAndOtherObligationsIncurred	0	usd
	gahr	Tenant Improvement Overage TenantImprovementOverage	3749000	usd
	gahr	Tenant Improvement Overage TenantImprovementOverage	1047000	usd
	gahr	Noncash Or Part Noncash Acquisition Mortgage Loans Payable Acquired Net Of Loan Discount NoncashOrPartNoncashAcquisitionMortgageLoansPayableAcquiredNetOfLoanDiscount	91472000	usd
	gahr	Noncash Or Part Noncash Acquisition Mortgage Loans Payable Acquired Net Of Loan Discount NoncashOrPartNoncashAcquisitionMortgageLoansPayableAcquiredNetOfLoanDiscount	0	usd
	gahr	Noncashreclassificationofnoncontrollinginterest Noncashreclassificationofnoncontrollinginterest	15282000	usd
	gahr	Noncashreclassificationofnoncontrollinginterest Noncashreclassificationofnoncontrollinginterest	0	usd
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	32913000	usd
CY2023Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	16559000	usd
CY2024Q2	gahr	Distributions Declared But Not Yet Paid To Limited Partnership Units DistributionsDeclaredButNotYetPaidToLimitedPartnershipUnits	875000	usd
CY2023Q2	gahr	Distributions Declared But Not Yet Paid To Limited Partnership Units DistributionsDeclaredButNotYetPaidToLimitedPartnershipUnits	875000	usd
CY2024Q2	gahr	Distributions Declared But Not Yet Paid To Restricted Stock Units DistributionsDeclaredButNotYetPaidToRestrictedStockUnits	357000	usd
CY2023Q2	gahr	Distributions Declared But Not Yet Paid To Restricted Stock Units DistributionsDeclaredButNotYetPaidToRestrictedStockUnits	123000	usd
CY2024Q2	gahr	Accrued Offering Costs AccruedOfferingCosts	511000	usd
CY2023Q2	gahr	Accrued Offering Costs AccruedOfferingCosts	1023000	usd
	gahr	Noncash Or Part Noncash Acquisition And Disposals Accounts And Other Receivables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsAccountsAndOtherReceivablesAssumed	343000	usd
	gahr	Noncash Or Part Noncash Acquisition And Disposals Accounts And Other Receivables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsAccountsAndOtherReceivablesAssumed	-1733000	usd
	gahr	Noncash Or Part Noncash Acquisitions And Disposals Increase Decrease In Other Assets Net NoncashOrPartNoncashAcquisitionsAndDisposalsIncreaseDecreaseInOtherAssetsNet	-3749000	usd
	gahr	Noncash Or Part Noncash Acquisitions And Disposals Increase Decrease In Other Assets Net NoncashOrPartNoncashAcquisitionsAndDisposalsIncreaseDecreaseInOtherAssetsNet	-920000	usd
	gahr	Noncash Or Part Noncash Acquisition And Disposals Payables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsPayablesAssumed	51000	usd
	gahr	Noncash Or Part Noncash Acquisition And Disposals Payables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsPayablesAssumed	-461000	usd
	gahr	Noncash Or Part Noncash Acquisition And Disposals Financing Obligations Assumed NoncashOrPartNoncashAcquisitionAndDisposalsFinancingObligationsAssumed	0	usd
	gahr	Noncash Or Part Noncash Acquisition And Disposals Financing Obligations Assumed NoncashOrPartNoncashAcquisitionAndDisposalsFinancingObligationsAssumed	12000	usd
	gahr	Noncash Or Part Noncash Acquisition And Disposals Security Deposits Prepaid Rent And Other Liabilities Assumed NoncashOrPartNoncashAcquisitionAndDisposalsSecurityDepositsPrepaidRentAndOtherLiabilitiesAssumed	-236000	usd
	gahr	Noncash Or Part Noncash Acquisition And Disposals Security Deposits Prepaid Rent And Other Liabilities Assumed NoncashOrPartNoncashAcquisitionAndDisposalsSecurityDepositsPrepaidRentAndOtherLiabilitiesAssumed	28000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. Organization and Description of Business</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview and Background</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Healthcare REIT, Inc., a Maryland corporation, is a self-managed real estate investment trust, or REIT, that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on outpatient medical buildings, senior housing, skilled nursing facilities, or SNFs, and other healthcare-related facilities. We also operate healthcare-related facilities utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a “RIDEA” structure (the provisions of the Internal Revenue Code of 1986, as amended, or the Code, authorizing the RIDEA structure were enacted as part of the Housing and Economic Recovery Act of 2008). Our healthcare facilities operated under a RIDEA structure include our senior housing operating properties, or SHOP, and our integrated senior health campuses. We have originated and acquired secured loans and may also originate and acquire other real estate-related investments on an infrequent and opportunistic basis. We generally seek investments that produce current income; however, we have selectively developed, and may continue to selectively develop, healthcare real estate properties. We have elected to be taxed as a REIT for U.S. federal income tax purposes. We believe that we have been organized and operated, and we intend to continue to operate, in conformity with the requirements for qualification and taxation as a REIT under the Code. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Partnership</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct substantially all of our operations through our operating partnership, and we are the sole general partner of our operating partnership. As of June 30, 2024 and December 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we owned 97.4% and 95.0%, respectively, of the partnership units, or OP units, in our operating partnership, and the remaining 2.6% and 5.0%, respectively, limited OP units were owned by AHI Group Holdings, LLC, which is owned and controlled by Jeffrey T. Hanson, the non-executive Chairman of our board of directors, or our board, Danny Prosky, our Chief Executive Officer, President and director, and Mathieu B. Streiff, one of our directors; Platform Healthcare Investor TII, LLC; Flaherty Trust; and a wholly owned subsidiary of Griffin Capital Company, LLC, or collectively, the Limited Partners. See Note 11, Redeemable Noncontrolling Interests, and Note 12, Equity — Noncontrolling Interests in Total Equity, for a further discussion of the ownership in our operating partnership.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Offerings and Listing</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued an aggregate 65,445,557 shares of Class T common stock and Class I common stock, for a total of $2,737,716,000 in gross offering proceeds, since February 26, 2014 in our initial public offerings and our distribution reinvestment plan, or DRIP, offerings. Our initial public offerings were terminated as of April 2019.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 9, 2024, pursuant to a Registration Statement filed with the United States Securities and Exchange Commission, or SEC, on Form S-11 (File No. 333-267464), as amended, we closed our underwritten public offering, or the 2024 Offering, through which we issued 64,400,000 shares of Common Stock, for a total of $772,800,000 in gross offering proceeds. Such amounts include the exercise in full of the underwriters’ overallotment option to purchase up to an additional 8,400,000 shares of Common Stock. These shares are listed on the New York Stock Exchange, or NYSE, under the trading symbol “AHR” and began trading on February 7, 2024. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the closing of the 2024 Offering, we are presenting Common Stock, Class T common stock and Class I common stock, or collectively, common stock, as separate classes within our condensed consolidated balance sheets and condensed consolidated statements of equity. Any references to “Common Stock” in this Quarterly Report on Form 10-Q refer to our NYSE-listed shares sold through the 2024 Offering, whereas Class T common stock and Class I common stock refer to our classes of common stock that were not NYSE-listed. This applies to all historical periods presented herein. On August 5, 2024, 180 days after the listing of our Common Stock shares on the NYSE, each share of our Class T common stock and Class I common stock automatically converted into one share of our listed Common Stock.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12, Equity — Common Stock, and Note 12, Equity — Distribution Reinvestment Plan, for a further discussion of our public offerings. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Real Estate Investments Portfolio</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate through four reportable business segments: integrated senior health campuses, outpatient medical, or OM, SHOP and triple-net leased properties. As of June 30, 2024, we owned and/or operated 318 buildings and integrated </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">senior health campuses, representing approximately 19,455,000 square feet of gross leasable area, for an aggregate contract purchase price of $4,612,670,000. In addition, as of June 30, 2024, we also owned a real estate-related debt investment purchased for $60,429,000.</span></div>
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q2	gahr	Number Of Buildings And Integrated Senior Health Campuses Owned And Or Operated NumberOfBuildingsAndIntegratedSeniorHealthCampusesOwnedAndOrOperated	318	campus
CY2024Q2	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	19455000	sqft
	gahr	Acquisition Aggregated Cost Of Acquired Properties Purchase Price Netof Disposals AcquisitionAggregatedCostOfAcquiredPropertiesPurchasePriceNetofDisposals	4612670000	usd
	gahr	Acquisition Aggregated Cost Of Acquired Real Estate Related Investment Purchase Price AcquisitionAggregatedCostOfAcquiredRealEstateRelatedInvestmentPurchasePrice	60429000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities, at the date of our condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the initial and recurring valuation of certain assets acquired and liabilities assumed through property acquisitions including through business combinations, goodwill and its impairment, revenues and grant income, allowance for credit losses, impairment of long-lived and intangible assets and contingencies. These estimates are made and evaluated on an ongoing basis using information that is currently available, as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.</span></div>
	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Resident and Tenant Receivables and Allowances </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Resident receivables, which are related to resident fees and services revenue, are carried net of an allowance for credit losses. An allowance is maintained for estimated losses resulting from the inability of residents and payors to meet the contractual obligations under their lease or service agreements. Substantially all of such allowances are recorded as direct reductions of resident fees and services revenue as contractual adjustments provided to third-party payors or implicit price concessions in our accompanying condensed consolidated statements of operations and comprehensive income (loss). Our determination of the adequacy of these allowances is based primarily upon evaluations of historical loss experience, the residents’ financial condition, security deposits, cash collection patterns by payor and by state, current economic conditions, future expectations in estimating credit losses and other relevant factors. Tenant receivables, which are related to real estate revenue, and unbilled deferred rent receivables are reduced for amounts where collectability is not probable, which are recognized as direct reductions of real estate revenue in our accompanying condensed consolidated statements of operations and comprehensive income (loss).</span></div>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	17037000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	14071000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	13212000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	9090000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	10680000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	4519000	usd
	gahr	Accounts Receivable Allowancefor Credit Loss Period Increase Decreasefrom Collectionsor Adjustments AccountsReceivableAllowanceforCreditLossPeriodIncreaseDecreasefromCollectionsorAdjustments	1555000	usd
	gahr	Accounts Receivable Allowancefor Credit Loss Period Increase Decreasefrom Collectionsor Adjustments AccountsReceivableAllowanceforCreditLossPeriodIncreaseDecreasefromCollectionsorAdjustments	3596000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	18014000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	15046000	usd
	gahr	Number Of Real Estate Investment To Be Disposed Of NumberOfRealEstateInvestmentToBeDisposedOf	0	property
CY2024Q2	gahr	Reimbursement Of Payroll Related Costs To Managers ReimbursementOfPayrollRelatedCostsToManagers	49298000	usd
CY2023Q4	gahr	Reimbursement Of Payroll Related Costs To Managers ReimbursementOfPayrollRelatedCostsToManagers	42698000	usd
CY2024Q2	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	45765000	usd
CY2023Q4	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	44548000	usd
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	32913000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	16557000	usd
CY2024Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	24138000	usd
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	23549000	usd
CY2024Q2	gahr	Accrued Development And Capital Expenditures AccruedDevelopmentAndCapitalExpenditures	22098000	usd
CY2023Q4	gahr	Accrued Development And Capital Expenditures AccruedDevelopmentAndCapitalExpenditures	24881000	usd
CY2024Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	4327315000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	4177595000	usd
CY2024Q2	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	817789000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	752157000	usd
CY2024Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3509526000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3425438000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	36866000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	37139000	usd
	us-gaap	Depreciation Depreciation	74001000	usd
	us-gaap	Depreciation Depreciation	73038000	usd
CY2024Q2	gahr	Capital Expenditures Incurred CapitalExpendituresIncurred	14647000	usd
	gahr	Capital Expenditures Incurred CapitalExpendituresIncurred	28284000	usd
	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	45841000	usd
	gahr	Lines Of Credit Related To Acquisition Of Properties LinesOfCreditRelatedToAcquisitionOfProperties	45000000	usd
	gahr	Number Of Real Estate Investment To Be Disposed Of NumberOfRealEstateInvestmentToBeDisposedOf	2	building
	gahr	Contract Sale Price Of Disposition ContractSalePriceOfDisposition	11136000	usd
CY2024Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	89058000	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	86935000	usd
CY2024Q2	gahr	Heldto Maturity Debt Securities Unamortizedclosingcosts HeldtoMaturityDebtSecuritiesUnamortizedclosingcosts	333000	usd
CY2024Q2	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1154000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	2066000	usd
CY2024Q2	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	80000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	179458000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	180470000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8428000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7711000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24782000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P6Y8M12D
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P7Y9M18D
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	11436000	usd
CY2024Q2	gahr	Finite Lived Intangible Liabilities Amortization Expenses Remainder Of Fiscal Year FiniteLivedIntangibleLiabilitiesAmortizationExpensesRemainderOfFiscalYear	510000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9373000	usd
CY2024Q2	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Two FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearTwo	956000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7578000	usd
CY2024Q2	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Three FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearThree	840000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7054000	usd
CY2024Q2	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Four FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFour	825000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6001000	usd
CY2024Q2	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFive	709000	usd
CY2024Q2	gahr	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	17757000	usd
CY2024Q2	gahr	Finite Lived Intangible Liabilities Amortization Expenses After Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesAfterYearFive	1693000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59199000	usd
CY2024Q2	gahr	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	5533000	usd
CY2024Q2	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	49280000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	47540000	usd
CY2024Q2	gahr	Prepaid Expense Deposits Other Assets And Deferred Tax Assets PrepaidExpenseDepositsOtherAssetsAndDeferredTaxAssets	37059000	usd
CY2023Q4	gahr	Prepaid Expense Deposits Other Assets And Deferred Tax Assets PrepaidExpenseDepositsOtherAssetsAndDeferredTaxAssets	33204000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	20036000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	19472000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	18377000	usd
CY2024Q2	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	7791000	usd
CY2023Q4	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	7231000	usd
CY2024Q2	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	17519000	usd
CY2023Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	17565000	usd
CY2024Q2	us-gaap	Derivative Assets DerivativeAssets	5879000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	1463000	usd
CY2024Q2	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	7783000	usd
CY2023Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	8494000	usd
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5201000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3830000	usd
CY2024Q2	gahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	2719000	usd
CY2023Q4	gahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	2544000	usd
	gahr	Lease Inducements Weighted Average Remaining Life LeaseInducementsWeightedAverageRemainingLife	P6Y4M24D
CY2023Q4	gahr	Lease Inducements Weighted Average Remaining Life LeaseInducementsWeightedAverageRemainingLife	P6Y10M24D
CY2024Q2	us-gaap	Incentive To Lessee IncentiveToLessee	2281000	usd
CY2023Q4	us-gaap	Incentive To Lessee IncentiveToLessee	2456000	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	155632000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	146141000	usd
CY2024Q2	gahr	Amortizationof Deferred Lease Inducements AmortizationofDeferredLeaseInducements	88000	usd
CY2024Q2	gahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	90	mortgageloan
CY2023Q4	gahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	76	mortgageloan
CY2024Q2	gahr	Number Of Variable Rate Mortgage Loans Payable NumberOfVariableRateMortgageLoansPayable	5	mortgageloan
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1253419000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1326313000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	135000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	167000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	14554000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	14371000	usd
CY2024Q2	us-gaap	Secured Debt SecuredDebt	1228597000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	1302396000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	1302396000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	1229847000	usd
	gahr	Proceeds From Mortgage Loans ProceedsFromMortgageLoans	27204000	usd
	gahr	Proceeds From Mortgage Loans ProceedsFromMortgageLoans	61077000	usd
	gahr	Assumption Of Debt In Business Combination AssumptionOfDebtInBusinessCombination	91472000	usd
	gahr	Assumption Of Debt In Business Combination AssumptionOfDebtInBusinessCombination	0	usd
	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	1566000	usd
	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	1136000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2776000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	632000	usd
	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	10115000	usd
	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	55127000	usd
	gahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	184445000	usd
	gahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	0	usd
	gahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	2257000	usd
	gahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	0	usd
CY2024Q2	us-gaap	Secured Debt SecuredDebt	1228597000	usd
CY2023Q2	us-gaap	Secured Debt SecuredDebt	1237565000	usd
CY2024Q1	gahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	176145000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	38094000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	302829000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	158331000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	55450000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	108169000	usd
CY2024Q2	gahr	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	590546000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1253419000	usd
CY2024Q2	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	388000	usd
CY2023Q2	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	4993000	usd
	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	6805000	usd
	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	4798000	usd
CY2024Q2	gahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2023Q4	gahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	33843000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	81598000	usd
	gahr	Noncontrolling Interest Reclassification From Equity NoncontrollingInterestReclassificationFromEquity	-21000	usd
	gahr	Noncontrolling Interest Reclassification From Equity NoncontrollingInterestReclassificationFromEquity	-41000	usd
	gahr	Noncontrolling Interest Reclassification To Equity NoncontrollingInterestReclassificationToEquity	15303000	usd
	gahr	Noncontrolling Interest Reclassification To Equity NoncontrollingInterestReclassificationToEquity	0	usd
	gahr	Redeemable Noncontrolling Interest Distributions RedeemableNoncontrollingInterestDistributions	3000	usd
	gahr	Redeemable Noncontrolling Interest Distributions RedeemableNoncontrollingInterestDistributions	904000	usd
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	10771000	usd
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	15954000	usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-7535000	usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-4422000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-32000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-486000	usd
CY2024Q2	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	220000	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	59873000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	724625000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	176145000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	545010000	usd
	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	37.16
CY2024Q2	gahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2023Q4	gahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2024Q2	gahr	Operating Partnership Units Outstanding Presented In Total Equity Percent OperatingPartnershipUnitsOutstandingPresentedInTotalEquityPercent	0.026
CY2024Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	89058000	usd
CY2024Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	93185000	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	86935000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	93304000	usd
CY2024Q2	us-gaap	Secured Debt SecuredDebt	1228597000	usd
CY2024Q2	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	1106268000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	1302396000	usd
CY2023Q4	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	1185260000	usd
CY2024Q2	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	778672000	usd
CY2024Q2	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	784480000	usd
CY2023Q4	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	1220137000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	1225890000	usd
CY2024Q2	gahr	Operating Lease Revenue OperatingLeaseRevenue	45207000	usd
CY2023Q2	gahr	Operating Lease Revenue OperatingLeaseRevenue	49216000	usd
CY2023Q2	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	9711000	usd
	gahr	Operating Lease Revenue OperatingLeaseRevenue	91213000	usd
	gahr	Operating Lease Revenue OperatingLeaseRevenue	91519000	usd
	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	18800000	usd
	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	19750000	usd
CY2024Q2	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	68919000	usd
CY2024Q2	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	130907000	usd
CY2024Q2	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	121639000	usd
CY2024Q2	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	115551000	usd
CY2024Q2	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	103935000	usd
CY2024Q2	gahr	Lessor Operating Lease Payment To Be Received After Year Four LessorOperatingLeasePaymentToBeReceivedAfterYearFour	494331000	usd
CY2024Q2	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1035282000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	9376000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	11473000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	555000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	297000	usd
CY2024Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	151000	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	66000	usd
CY2024Q2	us-gaap	Sublease Income SubleaseIncome	148000	usd
CY2023Q2	us-gaap	Sublease Income SubleaseIncome	172000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	9934000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	11664000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	20152000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	23396000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1116000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	600000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	308000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	157000	usd
	us-gaap	Sublease Income SubleaseIncome	293000	usd
	us-gaap	Sublease Income SubleaseIncome	328000	usd
	us-gaap	Lease Cost LeaseCost	21283000	usd
	us-gaap	Lease Cost LeaseCost	23825000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y2M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y2M12D
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M24D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0584
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0576
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0777
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0778
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	308000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	157000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	21000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	38000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3400000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1155000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	15873000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	30900000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	30811000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	31784000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	31750000	usd
CY2024Q2	gahr	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	136395000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	277513000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	98926000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	178587000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	52000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	31000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	0	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2024Q2	gahr	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	83000	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	80000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2023Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	6	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	458013000	usd
CY2024Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46568000	usd
CY2024Q2	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	504581000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	402564000	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	13323000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	88694000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11746000	usd
CY2024Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	15000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	45264000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	30596000	usd
CY2024Q2	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	388000	usd
CY2024Q2	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-2000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1035000	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	82000	usd
CY2024Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	3106000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-28057000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3612000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	686000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	2926000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	410622000	usd
CY2023Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	50568000	usd
CY2023Q2	gahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	6381000	usd
CY2023Q2	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	467571000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	372549000	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	14653000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	80369000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11774000	usd
CY2023Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	888000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	44701000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	40990000	usd
CY2023Q2	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	4993000	usd
CY2023Q2	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-2072000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-113000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1068000	usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	2589000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-34525000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11519000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	348000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-11867000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	910131000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	93983000	usd
	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	1004114000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	806193000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	27050000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	170871000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23574000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2797000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	88031000	usd
	us-gaap	Interest Expense InterestExpense	67034000	usd
	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	6805000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2261000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2240000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-344000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	4969000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-55583000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	886000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	964000	usd
	us-gaap	Profit Loss ProfitLoss	-78000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	819252000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	94164000	usd
	gahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	6381000	usd
	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	919797000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	742695000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	29848000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	147254000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24827000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1220000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	89371000	usd
	us-gaap	Interest Expense InterestExpense	80001000	usd
	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	4798000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-2204000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-419000	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	726000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2076000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	4197000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-70827000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38991000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	491000	usd
	us-gaap	Profit Loss ProfitLoss	-39482000	usd
CY2024Q2	us-gaap	Assets Assets	4644615000	usd
CY2023Q4	us-gaap	Assets Assets	4577933000	usd
CY2024Q2	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	504581000	usd
CY2023Q2	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	467571000	usd
	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	1004114000	usd
	gahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	919797000	usd
CY2024Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3509526000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3425438000	usd
CY2024Q2	gahr	Concentration Risk Number Of States That Generated At Least Ten Percent Of Annualized Base Rent ConcentrationRiskNumberOfStatesThatGeneratedAtLeastTenPercentOfAnnualizedBaseRent	2	state
CY2024Q2	gahr	Minimum Percent Share Of Each State Annualized Base Rent That Company Owned MinimumPercentShareOfEachStateAnnualizedBaseRentThatCompanyOwned	0.100
CY2024Q2	gahr	Number Of Tenants With More Than Ten Percent Of Annual Base Rent NumberOfTenantsWithMoreThanTenPercentOfAnnualBaseRent	0	tenant
CY2024Q2	gahr	Minimum Percent Share Of Annualized Base Rent Accounted By Tenants MinimumPercentShareOfAnnualizedBaseRentAccountedByTenants	0.100
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	1979000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-12183000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1913000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-38055000	usd
CY2024Q2	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	-1000	usd
CY2023Q2	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	1978000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-12183000	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-1913000	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-38055000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130532144	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66033345	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	117413643	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66029779	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	157745	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	0	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	0	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	0	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	130689889	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66033345	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	117413643	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66029779	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001632970-24-000085-index-headers.html	Edgar Link	pending
0001632970-24-000085-index.html	Edgar Link	pending
0001632970-24-000085.txt	Edgar Link	pending
0001632970-24-000085-xbrl.zip	Edgar Link	pending
ex102-2024xq210xq.htm	Edgar Link	pending
ex103-2024xq210xq.htm	Edgar Link	pending
ex311-2024xq210xqahr.htm	Edgar Link	pending
ex312-2024xq210xqahr.htm	Edgar Link	pending
ex321-2024xq210xqahr.htm	Edgar Link	pending
ex322-2024xq210xqahr.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gahr-20240630.htm	Edgar Link	pending
gahr-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
gahr-20240630_def.xml	Edgar Link	unprocessable
gahr-20240630_lab.xml	Edgar Link	unprocessable
gahr-20240630_pre.xml	Edgar Link	unprocessable
gahr-20240630_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gahr-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AHR
American Healthcare REIT, Inc. Stock $ahr

2024 Q3 Form 10-Q Financial Statement

#000163297024000085 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR American Healthcare REIT, Inc. Stock $ahr

2024 Q3 Form 10-Q Financial Statement

#000163297024000085 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR
American Healthcare REIT, Inc. Stock $ahr